Lifevantage (LFVN) Form 4: Executive PRSU Vesting and Insider Sale Detailed

Rhea-AI Filing Summary

Julie Boyster, identified as an Officer (Chief Marketing Officer), reported Section 16 transactions in Lifevantage Corp (LFVN) on 08/31/2025. Two grants of Performance Restricted Stock Units (PRSUs) converted or vested resulting in acquisitions: 18,934 shares (from a PRSU grant on 08/24/2023) and 27,966 shares (from a PRSU grant on 08/26/2024). The filing states PRSUs convert into common stock on a one-for-one basis. The holder also reported a disposition of 23,293 shares at a price of $13.10 each. Following the reported transactions, the form shows the reporting person beneficially owned 151,923 shares directly. The form is signed by a power of attorney on behalf of Julie Boyster.

Positive

• Performance-based compensation vested: PRSUs from 08/24/2023 and 08/26/2024 converted into 18,934 and 27,966 common shares respectively, indicating achievement of vesting criteria.
• One-for-one conversion: The PRSUs convert into common stock on a 1:1 basis, making the equity impact straightforward and transparent.

Negative

• Insider sale: Reporting person disposed of 23,293 shares at $13.10, reducing direct holdings.
• Partial reduction in immediately held shares: Despite vesting, the sale reduces available direct ownership relative to gross acquisitions.

Insights

Corporate Governance Expert

TL;DR: Officer vested performance-based equity and sold a portion of holdings; shows routine insider compensation realization, not necessarily signaling corporate change.

The filing documents that performance-restricted stock units granted in 2023 and 2024 vested or converted on 08/31/2025 into 18,934 and 27,966 common shares respectively, reflecting compensation tied to time and financial targets. These PRSUs convert one-for-one to common stock, aligning executive pay with shareholder equity. The sale of 23,293 shares at $13.10 is a direct disposition reducing on-hand shares. From a governance perspective, these are standard actions: equity vesting as earned and partial monetization by the executive. No regulatory or governance red flags are apparent within the form's disclosures.

Securities Analyst

TL;DR: Insider received ~46,900 shares via vested PRSUs and sold ~23,300 shares; net increase in holdings remains positive per the filing.

The report shows acquisitions through vesting of PRSUs totaling 46,900 shares (18,934 + 27,966) and a contemporaneous disposition of 23,293 shares at $13.10. The conversion mechanics are one-for-one, simplifying share count impact. The filing lists 151,923 shares beneficially owned after these transactions. These movements alter insider supply but reflect compensation realization rather than an unusual trading pattern based on the disclosed data.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Boyster Julie

(Last) (First) (Middle)

3300 TRIUMPH BLVD, SUITE 700

(Street)

LEHI UT 84043

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Lifevantage Corp [ LFVN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Marketing Officer

3. Date of Earliest Transaction (Month/Day/Year)
08/31/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/31/2025		M		18,934(1)	A	$0	147,250	D
Common Stock	08/31/2025		M		27,966(2)	A	$0	175,216	D
Common Stock	08/31/2025		F		23,293	D	$13.1	151,923	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Performance Restricted Stock Units	(3)	08/31/2025		M			18,934	(1)	(1)	Common Stock	18,934	$0	6,312	D
Performance Restricted Stock Units	(3)	08/31/2025		M			27,966	(2)	(2)	Common Stock	27,966	$0	13,983	D

Explanation of Responses:

1. On August 24, 2023, the reporting person was granted Performance Restricted Stock Units ("PRSUs") which vest upon achievement of previously established time-based and financial performance criteria.

2. On August 26, 2024, the reporting person was granted PRSUs which vest upon achievement of previously established time-based and financial performance criteria.

3. PRSUs convert into common stock on a one-for-one basis.

Remarks:

	/s/ Alissa Neufeld, Power of Attorney for Julie Boyster	09/03/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transactions did Julie Boyster report on Form 4 for LFVN?

The filing reports vesting/conversion of PRSUs into 18,934 and 27,966 common shares and a sale of 23,293 shares at $13.10 on 08/31/2025.

How do the reported PRSUs convert to common stock?

The form states the Performance Restricted Stock Units convert into common stock on a one-for-one basis.

What was the reporting person's role at Lifevantage (LFVN)?

The reporting person is listed as an Officer with the title Chief Marketing Officer.

How many shares did the reporting person beneficially own after the transactions?

Following the reported transactions, the filing shows the reporting person beneficially owned 151,923 shares directly.

When were the PRSUs originally granted that vested in this filing?

The PRSUs were granted on 08/24/2023 (resulting in 18,934 shares) and 08/26/2024 (resulting in 27,966 shares).